Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prostate Cancer Awareness and Initiative for Screening in the European Union
Sponsor: European Association of Urology Research Foundation
Summary
PRAISE-U was initiated on the 1st of April 2023 and is set to last for three years. This collaborative effort involves 25 institutions across 12 countries, all driven by a shared objective: to rationalize prostate cancer screening in Europe and enhance patient outcomes. PRAISE-U advocates for EU member states to offer exceptional clinical standards, incorporating cutting-edge personalized approaches to enable timely detection of prostate cancer in individuals who can benefit from early treatment. To assess the functionality, feasibility, and long-term viability of a risk-based algorithm, the consortium will collaborate with pilot sites in Spain, Poland, Ireland, and Lithuania.
Key Details
Gender
MALE
Age Range
50 Years - 69 Years
Study Type
OBSERVATIONAL
Enrollment
20000
Start Date
2024-06-01
Completion Date
2026-04-01
Last Updated
2025-08-15
Healthy Volunteers
Yes
Conditions
Interventions
Risk-based screening algorithm
Risk-based screening algorithm
Locations (5)
University College Dublin
Dublin, Ireland
National Cancer Institute
Vilnius, Lithuania
Lower Silesian Oncology, Pulmonology and Hematology Center
Wroclaw, Lower Silesian Voivodeship, Poland
Public Health Directorate, SERGAS
Santiago de Compostela, Galicia, Spain
Althaia Foundation
Manresa, Spain